Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2024-05-22 M&A Activity
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Accord de fabrication et de fourniture de 500 000 corps creux pour le compte de Bizzell Europe
M&A Activity Classification · 99% confidence The document is titled "Communiqué de presse" (Press Release) dated May 22, 2024, announcing a significant commercial agreement (Accord de fabrication et de fourniture) between Europlasma and Bizzell Corporation regarding 500,000 hollow bodies for nearly 140 million euros. This is a material, non-financial event announcement intended for the market. It is not a full Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a Call Transcript (CT). It details a major business development, which often falls under general regulatory announcements or specific corporate actions. Since it is a press release announcing a major contract and potential future shareholding changes, it fits best as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on the financing aspect, but here the focus is the contract itself. Given the nature of a press release announcing a significant business contract, RNS (Regulatory Filings) is the most appropriate general category for material, non-standardized announcements not covered by other specific codes like ER or 10-K. The length (6693 chars) is substantial enough to be the primary document, not just an announcement of another document (RPA).
2024-05-22 French
EUROPLASMA: Résultats annuels 2023
Earnings Release Classification · 100% confidence The document is titled "Résultats annuels 2023" (Annual Results 2023) and presents detailed consolidated financial statements, including income statements, cash flow statements, and balance sheets for the period ending December 31, 2023. It explicitly mentions that the consolidated accounts are '2023 audités par le collège des Commissaires aux Comptes' (2023 audited by the Board of Statutory Auditors). Although it is presented as a press release ('Communiqué de presse'), the content is the comprehensive annual financial disclosure, which aligns most closely with the content of an Annual Report (10-K) or a comprehensive Interim/Annual Report. Since it covers the full fiscal year (2023) and contains audited figures, it is classified as an Annual Report (10-K) equivalent, even if the format is a press release summarizing the findings. The length (over 31,000 characters) confirms it is not a mere announcement (RPA/RNS). FY 2023
2024-05-21 French
EUROPLASMA: Bizzell Europe entre au capital de Valdunes Industries à hauteur de 25% pour 5M
M&A Activity Classification · 99% confidence The document is titled "Communiqué de presse" (Press Release) dated May 17, 2024. It announces a significant corporate event: Bizzell Europe entering the capital of Valdunes Industries (a subsidiary of Europlasma) for 25% stake for 5M€. This is a formal announcement of a transaction that impacts the capital structure and ownership, but it is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER). It is a specific announcement regarding a corporate transaction/financing event. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate fit for an announcement detailing a significant equity investment and capital structure change in a subsidiary, even though it is structured as a press release. It is not a general regulatory filing (RNS) because it fits the specific 'CAP' definition better.
2024-05-17 French
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 avril 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated May 13, 2024, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 30 avril 2024" (Information relating to the total number of voting rights and shares comprising the capital as of April 30, 2024). It explicitly states the total number of shares and voting rights as required by French commercial code (articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'Autorité des marchés financiers). This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement, often related to capital structure updates or general shareholder information, but it does not fit perfectly into the provided categories like DIV, SHA, or MRQ. Since it is a formal announcement of a key capital structure metric required by the regulator (AMF), and it is not a full report, a dividend notice, or a major shareholding change above a threshold, it most closely aligns with a general regulatory announcement or a specific capital structure update. Given the options, it is a formal declaration about the capital structure. It is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ - which is for changes crossing thresholds), or Share Issue/Capital Change (SHA - which usually implies an issuance/buyback event). However, the closest fit for a formal, periodic declaration about the total number of shares/voting rights, which is a mandatory regulatory disclosure, is often captured under general regulatory filings or specific capital updates. Since it is a declaration of the total number of shares/voting rights, it is a specific type of capital structure disclosure. If we must choose from the list, it is a formal regulatory disclosure. It is not a DVA (Voting Results), not a DIV (Dividend), not a SHA (New Issue). It is a declaration of the current state of the capital base. In many contexts, this falls under general regulatory filings (RNS) or sometimes specific capital updates (CAP). Given the precise nature of the data (total shares/votes), it is a fundamental piece of capital information. Since it is a mandatory disclosure of the capital base count, it is best classified as a Regulatory Filing (RNS) as it doesn't fit the more specific capital action codes (SHA, CAP).
2024-05-13 French
EUROPLASMA: Report de la publication des états financiers 2023 du Groupe
Report Publication Announcement Classification · 98% confidence The document is a press release dated April 30, 2024, titled "Report de la publication des états financiers 2023 du Groupe" (Postponement of the publication of the Group's 2023 financial statements). It provides preliminary, unaudited financial highlights for 2023 (Revenue, EBITDA, Net Result, Cash Position) and announces that the full annual accounts publication is delayed until May. Since this document is an announcement about the *timing* and *status* of a major financial report (the 2023 annual accounts), and it provides key figures but is not the comprehensive report itself, it fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K, nor is it a standard Earnings Release (ER) which usually accompanies the full results, but rather a notice about the delay of the annual report publication.
2024-04-30 French
EUROPLASMA: MISE EN PLACE D’UN NOUVEAU FINANCEMENT OBLIGATAIRE D’UN MONTANT NOMINAL MAXIMUM DU CAPITALE 30 M€ SUR 36 MOIS SOUS FORME D’OCABSA IMPLIQUANT UNE DILUTION POTENTIELLE DE PLUS DE 99% D
Capital/Financing Update Classification · 98% confidence The document is a press release dated April 24, 2024, announcing the establishment of a new bond financing arrangement (OCABSA - Obligations Convertibles en Actions avec Bons de Souscription d'Actions attachés) up to a maximum nominal amount of 30 million Euros over 36 months with Environmental Performance Financing. This explicitly details a fundraising/financing activity and its structure (convertible bonds, dilution risk, use of funds). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it mentions the Annual Report (Rapport Financier Annuel) for risk factors, the primary purpose of this document is the announcement of the financing deal itself, not the release of the annual report or a quarterly report. It is not a short announcement linking to a full report, as the details of the financing are contained within the text and annexes, making it a substantive announcement rather than just a 'Report Publication Announcement' (RPA).
2024-04-24 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.